Antiasthmatic Drugs Pranlukast Powder CAS 103177-37-3 Pranlukast

• Powder: Yes
• Customized: Customized
• Certification: GMP, ISO 9001, USP, BP
• Suitable for: Elderly, Adult
• State: Powder
• Purity: >98%
• Model NO.: TGY201906100702
• Product Name: Pranlukast
• Appearance: White Powder
• CAS No.: 103177-37-3
• Molecular Formula: C27h23n5o4
• Molecular Weight: 481.5
• Assay: 99%
• Coa: Available
• Sample: Available
• MOQ: Any Quantitiy
• Service: OEM
• Grade: Pharmaceutical Grade
• Test Method: USP;GMP
• Storage: Cool Dry Area
• Shelf Life: 24 Months Properly
• Certificate: ISO9001:2008
• Transport Package: Boil Bag
• Specification: HPLC 99%
• Trademark: TGY
• Origin: Xi′an, Shaanxi, China (Mainland)
• HS Code: 29225090
• Production Capacity: 5000kg/Month

Product Description

Basic INFORMATION

Name: Pranlukast

CAS Number:103177-37-3

Formula: C27H23N5O4

Molecular Weight: 481.50

EINECS:201-616-4

Color:White 

Form:Powder

Melting point:236-238°C

Storage condition:Store at +4°C

Pranlukast is a common respiratory drug, it belongs to asthma drugs , it is the cysteinyl leukotrienes (LTs) receptor antagonist and it can bind to LTC4, LTD4, LTE4 receptors selectively to antagonize their effect . Roles and application are similar to zafirlukast. It is clinically used for the prevention of bronchial asthma. Oral 225mg once, 2 times one day, morning and evening after meal. After taking ,there may be gastrointestinal reactions,or there may be nausea, vomiting, abdominal pain, diarrhea or constipation, sometimes , fever, rash, pruritus and liver function abnormalities such as serum aminotransferase or bilirubin increase are visible . Pregnant women should use with caution , the elderly should take appropriate reductions. This product can not alleviate the onset of asthma.

1, zafirlukast: it is effective for mild to moderate asthma ,it can cause improvement in dose-dependent lung function, and reduce the amount of β agonists. Absorption of the product is affected by food, it should not be taken together with food. Oral each 20mg, 2 times/d. 

2, montelukast: it is valid for intermittent or persistent asthma in adults and children. This product is approved by the FDA for the treatment of children aged 6 to 12. Absorption of the product is not affected by food, it can be taken with food . Oral each 10mg, once/d.

3, pranlukast: it is used for mild to moderate asthma, pranlukast can increase patients maximum expiratory flow,and improve asthma symptoms, it can be used as a daily treatment of chronic asthma. Each oral 450mg, 2 times/d.